Device-measured physical activity and cardiovascular disease risk in adolescent childhood cancer survivors. A physical activity in childhood cancer survivors (PACCS) study.
accelerometry
cardiometabolic risk
cardiovascular disease risk
childhood cancer survivors
physical activity
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
24
06
2022
accepted:
03
08
2022
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
13
9
2022
Statut:
epublish
Résumé
We aimed to compare cardiovascular disease (CVD) risk factors in childhood cancer survivors (CCS) with age- and sex-stratified reference material and examine the association between physical activity (PA) intensities and CVD risk factors in CCS. Within the cross-sectional, multicenter We included 157 CCS aged on average 13.4 years at inclusion and 8.2 years from diagnosis. Male CCS had lower VO Male adolescent CCS had less favorable values of CVD risk factors compared to references. VPA in adolescent CCS is associated with clinically meaningful favorable values of CVD risk factors.
Identifiants
pubmed: 36090557
doi: 10.3389/fped.2022.977365
pmc: PMC9453306
doi:
Types de publication
Journal Article
Langues
eng
Pagination
977365Informations de copyright
Copyright © 2022 Bratteteig, Anderssen, Rueegg, Ruud, Torsvik, Kriemler and Grydeland.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
JAMA. 2013 Jun 12;309(22):2371-2381
pubmed: 23757085
J Pediatr Hematol Oncol. 2019 Oct;41(7):e450-e458
pubmed: 30688830
J Clin Oncol. 2009 May 10;27(14):2328-38
pubmed: 19332714
Psychol Sport Exerc. 2020 Sep;50:
pubmed: 32831643
Qual Life Res. 2018 Jun;27(6):1431-1443
pubmed: 29372438
Clin Sci. 1971 May;40(5):419-31
pubmed: 5556096
J Adolesc Young Adult Oncol. 2016 Mar;5(1):8-15
pubmed: 26812453
Am J Cardiol. 1988 Nov 15;62(16):1109-12
pubmed: 3189175
J Clin Oncol. 2014 Nov 10;32(32):3643-50
pubmed: 25311213
Pediatr Blood Cancer. 2012 Jul 15;59(1):155-60
pubmed: 22184098
Circulation. 2006 Dec 12;114(24):2710-38
pubmed: 17130340
J Clin Oncol. 2015 Nov 10;33(32):3774-80
pubmed: 26304888
JMIR Res Protoc. 2022 Mar 8;11(3):e35838
pubmed: 35258456
Lancet. 2006 Jul 22;368(9532):299-304
pubmed: 16860699
J Am Coll Cardiol. 2017 Sep 26;70(13):1637-1646
pubmed: 28935041
Appl Physiol Nutr Metab. 2016 Jun;41(6 Suppl 3):S197-239
pubmed: 27306431
Int J Sports Med. 2020 Mar;41(3):141-153
pubmed: 31935777
Med Sci Sports Exerc. 2008 Jan;40(1):181-8
pubmed: 18091006
Int J Cancer. 2017 Jan 1;140(1):62-74
pubmed: 27632765
Pediatr Endocrinol Rev. 2012 Nov;10(1):130-9
pubmed: 23469390
J Adolesc Young Adult Oncol. 2019 Oct;8(5):602-609
pubmed: 31120346
Med Sci Sports Exerc. 2011 Jul;43(7):1360-8
pubmed: 21131873
Curr Opin Pediatr. 2007 Feb;19(1):23-31
pubmed: 17224658
N Engl J Med. 1998 Jun 4;338(23):1650-6
pubmed: 9614255
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894
pubmed: 28089956
Cancer. 2021 May 15;127(10):1690-1698
pubmed: 33405260
Int J Pediatr Obes. 2009;4(1):2-27
pubmed: 18720173
Cancer. 2014 Sep 1;120(17):2742-50
pubmed: 25070001
Biol Blood Marrow Transplant. 2015 Jul;21(7):1278-83
pubmed: 25865649
Cancer Causes Control. 2013 Feb;24(2):313-21
pubmed: 23187859
Diabetologia. 2007 Sep;50(9):1832-1840
pubmed: 17641870
Pediatr Obes. 2020 Jan;15(1):e12578
pubmed: 31709781
Atherosclerosis. 2018 Nov;278:299-306
pubmed: 30477756
PLoS One. 2018 Aug 9;13(8):e0201449
pubmed: 30092052
Pediatr Blood Cancer. 2015 Feb;62(2):305-310
pubmed: 25327738
J Adolesc Health. 1993 May;14(3):190-5
pubmed: 8323929
CA Cancer J Clin. 2020 Nov;70(6):443-459
pubmed: 32940362
Acta Physiol Pharmacol Bulg. 2003;27(2-3):47-51
pubmed: 14570147
J Adolesc Health. 2020 May;66(5):597-602
pubmed: 31974011